Q2 2018

Filed Jul 24, 2018 · 10-Q · 24 days after period end · 0001091818-18-000150

Q2 2018 · 10-Q

Revenue

$5.06K

no prior Q2 2017 on file

Net Income

-$28.53K

no prior Q2 2017 on file

EPS Diluted

$0.00

no prior Q2 2017 on file

Gross Profit$1,417—

Operating Income

Same quarter

no prior Q2 2017 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Jun 30, 2018 · filed Jul 24, 2018 · 24 d after period end

Bioforce Nanosciences Holdings, Inc. · CIK 1310488 · Engraved from SEC EDGAR